‘Flying blind’: Why experts fear Treasury’s China biotech investment crackdown will backfire

The U.S. Treasury's COINS Act proposal aims to shield U.S. biotech from Chinese competition, but insiders warn it will backfire.

As lawyers scramble to decipher an ambiguous ban on cross-border "joint ventures," they flag that Washington's national security priorities have expanded.